nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCB1—colon cancer	0.193	1	CbGaD
Lamivudine—ABCC3—Fluorouracil—colon cancer	0.0561	0.0985	CbGbCtD
Lamivudine—SLC22A3—Irinotecan—colon cancer	0.055	0.0965	CbGbCtD
Lamivudine—ABCC3—Vincristine—colon cancer	0.0511	0.0897	CbGbCtD
Lamivudine—SLC22A3—Vincristine—colon cancer	0.048	0.0843	CbGbCtD
Lamivudine—ABCC4—Fluorouracil—colon cancer	0.0428	0.0752	CbGbCtD
Lamivudine—ABCC1—Irinotecan—colon cancer	0.0359	0.063	CbGbCtD
Lamivudine—ABCC1—Vincristine—colon cancer	0.0314	0.0551	CbGbCtD
Lamivudine—ABCC3—Methotrexate—colon cancer	0.0309	0.0543	CbGbCtD
Lamivudine—ABCC2—Irinotecan—colon cancer	0.0266	0.0466	CbGbCtD
Lamivudine—ABCG2—Irinotecan—colon cancer	0.024	0.0422	CbGbCtD
Lamivudine—ABCC4—Methotrexate—colon cancer	0.0236	0.0415	CbGbCtD
Lamivudine—ABCC2—Vincristine—colon cancer	0.0232	0.0408	CbGbCtD
Lamivudine—ABCG2—Fluorouracil—colon cancer	0.023	0.0405	CbGbCtD
Lamivudine—ABCG2—Vincristine—colon cancer	0.021	0.0368	CbGbCtD
Lamivudine—ABCC1—Methotrexate—colon cancer	0.019	0.0333	CbGbCtD
Lamivudine—ABCC2—Methotrexate—colon cancer	0.0141	0.0247	CbGbCtD
Lamivudine—ABCG2—Methotrexate—colon cancer	0.0127	0.0223	CbGbCtD
Lamivudine—SLC22A6—Methotrexate—colon cancer	0.0103	0.0181	CbGbCtD
Lamivudine—ABCB1—Irinotecan—colon cancer	0.00866	0.0152	CbGbCtD
Lamivudine—ABCB1—Vincristine—colon cancer	0.00757	0.0133	CbGbCtD
Lamivudine—ABCB1—Methotrexate—colon cancer	0.00458	0.00804	CbGbCtD
Lamivudine—ABCC2—bile—colon cancer	0.00392	0.0526	CbGeAlD
Lamivudine—PCYT2—renal system—colon cancer	0.00312	0.042	CbGeAlD
Lamivudine—PCYT2—digestive system—colon cancer	0.00256	0.0344	CbGeAlD
Lamivudine—DCK—Topotecan—Irinotecan—colon cancer	0.0024	1	CbGdCrCtD
Lamivudine—NT5C—renal system—colon cancer	0.00227	0.0304	CbGeAlD
Lamivudine—PGK1—digestive system—colon cancer	0.0022	0.0296	CbGeAlD
Lamivudine—PCYT1A—renal system—colon cancer	0.00213	0.0286	CbGeAlD
Lamivudine—PCYT2—liver—colon cancer	0.00191	0.0256	CbGeAlD
Lamivudine—NT5C—lymphoid tissue—colon cancer	0.00188	0.0253	CbGeAlD
Lamivudine—NME2—embryo—colon cancer	0.00177	0.0238	CbGeAlD
Lamivudine—PCYT1A—digestive system—colon cancer	0.00174	0.0234	CbGeAlD
Lamivudine—Gemcitabine—TYMS—colon cancer	0.00171	0.798	CrCbGaD
Lamivudine—NT5C—vagina—colon cancer	0.00164	0.022	CbGeAlD
Lamivudine—PGK1—liver—colon cancer	0.00164	0.022	CbGeAlD
Lamivudine—NME1-NME2—liver—colon cancer	0.00149	0.0201	CbGeAlD
Lamivudine—NME2—epithelium—colon cancer	0.00144	0.0194	CbGeAlD
Lamivudine—CMPK1—smooth muscle tissue—colon cancer	0.00142	0.0191	CbGeAlD
Lamivudine—NME1—renal system—colon cancer	0.00142	0.0191	CbGeAlD
Lamivudine—NT5C—liver—colon cancer	0.00138	0.0186	CbGeAlD
Lamivudine—CMPK1—renal system—colon cancer	0.00137	0.0184	CbGeAlD
Lamivudine—ABCC3—gall bladder—colon cancer	0.00136	0.0183	CbGeAlD
Lamivudine—NME2—renal system—colon cancer	0.00134	0.018	CbGeAlD
Lamivudine—PCYT1A—liver—colon cancer	0.0013	0.0175	CbGeAlD
Lamivudine—NME1—lymphoid tissue—colon cancer	0.00118	0.0159	CbGeAlD
Lamivudine—NME1—digestive system—colon cancer	0.00117	0.0157	CbGeAlD
Lamivudine—NME1-NME2—lymph node—colon cancer	0.00115	0.0154	CbGeAlD
Lamivudine—CMPK1—lymphoid tissue—colon cancer	0.00114	0.0153	CbGeAlD
Lamivudine—CMPK1—digestive system—colon cancer	0.00112	0.0151	CbGeAlD
Lamivudine—NME2—lymphoid tissue—colon cancer	0.00111	0.0149	CbGeAlD
Lamivudine—NME2—digestive system—colon cancer	0.0011	0.0148	CbGeAlD
Lamivudine—NME1—bone marrow—colon cancer	0.00108	0.0144	CbGeAlD
Lamivudine—NT5C—lymph node—colon cancer	0.00106	0.0143	CbGeAlD
Lamivudine—CMPK1—bone marrow—colon cancer	0.00104	0.0139	CbGeAlD
Lamivudine—CMPK1—vagina—colon cancer	0.000992	0.0133	CbGeAlD
Lamivudine—DCK—embryo—colon cancer	0.000901	0.0121	CbGeAlD
Lamivudine—NME1—liver—colon cancer	0.000869	0.0117	CbGeAlD
Lamivudine—CMPK1—liver—colon cancer	0.000837	0.0112	CbGeAlD
Lamivudine—SLC22A2—renal system—colon cancer	0.000824	0.0111	CbGeAlD
Lamivudine—NME2—liver—colon cancer	0.000818	0.011	CbGeAlD
Lamivudine—SLC22A3—embryo—colon cancer	0.000735	0.00987	CbGeAlD
Lamivudine—SLC22A2—digestive system—colon cancer	0.000676	0.00908	CbGeAlD
Lamivudine—NME1—lymph node—colon cancer	0.000666	0.00895	CbGeAlD
Lamivudine—ABCC3—renal system—colon cancer	0.000653	0.00878	CbGeAlD
Lamivudine—CMPK1—lymph node—colon cancer	0.000642	0.00862	CbGeAlD
Lamivudine—NME2—lymph node—colon cancer	0.000627	0.00843	CbGeAlD
Lamivudine—SLC22A1—renal system—colon cancer	0.000582	0.00782	CbGeAlD
Lamivudine—SLC22A3—smooth muscle tissue—colon cancer	0.000578	0.00776	CbGeAlD
Lamivudine—DCK—lymphoid tissue—colon cancer	0.000567	0.00761	CbGeAlD
Lamivudine—DCK—digestive system—colon cancer	0.00056	0.00752	CbGeAlD
Lamivudine—SLC22A3—renal system—colon cancer	0.000556	0.00747	CbGeAlD
Lamivudine—ABCC4—renal system—colon cancer	0.000539	0.00724	CbGeAlD
Lamivudine—ABCC3—digestive system—colon cancer	0.000536	0.0072	CbGeAlD
Lamivudine—ABCC2—renal system—colon cancer	0.000522	0.00701	CbGeAlD
Lamivudine—DCK—bone marrow—colon cancer	0.000516	0.00693	CbGeAlD
Lamivudine—DCK—vagina—colon cancer	0.000494	0.00664	CbGeAlD
Lamivudine—ABCC4—digestive system—colon cancer	0.000442	0.00594	CbGeAlD
Lamivudine—Gemcitabine—ABCB1—colon cancer	0.000434	0.202	CrCbGaD
Lamivudine—ABCC2—digestive system—colon cancer	0.000428	0.00575	CbGeAlD
Lamivudine—SLC22A1—vagina—colon cancer	0.000421	0.00566	CbGeAlD
Lamivudine—DCK—liver—colon cancer	0.000417	0.0056	CbGeAlD
Lamivudine—ABCB1—blood vessel—colon cancer	0.000416	0.00558	CbGeAlD
Lamivudine—ABCC4—bone marrow—colon cancer	0.000408	0.00548	CbGeAlD
Lamivudine—SLC22A3—vagina—colon cancer	0.000403	0.00541	CbGeAlD
Lamivudine—ABCC3—liver—colon cancer	0.000399	0.00536	CbGeAlD
Lamivudine—SLC22A1—liver—colon cancer	0.000356	0.00478	CbGeAlD
Lamivudine—SLC22A3—liver—colon cancer	0.00034	0.00457	CbGeAlD
Lamivudine—ABCC1—vagina—colon cancer	0.000333	0.00447	CbGeAlD
Lamivudine—ABCC4—liver—colon cancer	0.000329	0.00443	CbGeAlD
Lamivudine—DCK—lymph node—colon cancer	0.00032	0.00429	CbGeAlD
Lamivudine—ABCC2—liver—colon cancer	0.000319	0.00428	CbGeAlD
Lamivudine—ABCC3—lymph node—colon cancer	0.000306	0.00411	CbGeAlD
Lamivudine—ABCG2—bone marrow—colon cancer	0.000288	0.00387	CbGeAlD
Lamivudine—ABCC1—liver—colon cancer	0.000281	0.00377	CbGeAlD
Lamivudine—ABCG2—vagina—colon cancer	0.000276	0.0037	CbGeAlD
Lamivudine—SLC22A3—lymph node—colon cancer	0.000261	0.0035	CbGeAlD
Lamivudine—ABCC4—lymph node—colon cancer	0.000253	0.00339	CbGeAlD
Lamivudine—ABCB1—embryo—colon cancer	0.000248	0.00333	CbGeAlD
Lamivudine—ABCC2—lymph node—colon cancer	0.000245	0.00328	CbGeAlD
Lamivudine—ABCG2—liver—colon cancer	0.000233	0.00312	CbGeAlD
Lamivudine—ABCC1—lymph node—colon cancer	0.000215	0.00289	CbGeAlD
Lamivudine—ABCB1—epithelium—colon cancer	0.000202	0.00272	CbGeAlD
Lamivudine—Convulsion—Vincristine—colon cancer	0.000202	0.00219	CcSEcCtD
Lamivudine—Anaemia—Fluorouracil—colon cancer	0.000201	0.00218	CcSEcCtD
Lamivudine—Loss of consciousness—Irinotecan—colon cancer	0.0002	0.00217	CcSEcCtD
Lamivudine—Myalgia—Vincristine—colon cancer	0.000199	0.00216	CcSEcCtD
Lamivudine—Cough—Irinotecan—colon cancer	0.000198	0.00215	CcSEcCtD
Lamivudine—Hyperglycaemia—Capecitabine—colon cancer	0.000197	0.00214	CcSEcCtD
Lamivudine—Leukopenia—Fluorouracil—colon cancer	0.000195	0.00211	CcSEcCtD
Lamivudine—Depression—Capecitabine—colon cancer	0.000194	0.00211	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000193	0.00209	CcSEcCtD
Lamivudine—Renal failure—Capecitabine—colon cancer	0.000191	0.00208	CcSEcCtD
Lamivudine—Discomfort—Irinotecan—colon cancer	0.000191	0.00207	CcSEcCtD
Lamivudine—Neuropathy peripheral—Capecitabine—colon cancer	0.000191	0.00207	CcSEcCtD
Lamivudine—Anaphylactic shock—Vincristine—colon cancer	0.000191	0.00207	CcSEcCtD
Lamivudine—Oedema—Vincristine—colon cancer	0.000191	0.00207	CcSEcCtD
Lamivudine—Jaundice—Capecitabine—colon cancer	0.00019	0.00206	CcSEcCtD
Lamivudine—Stomatitis—Capecitabine—colon cancer	0.00019	0.00206	CcSEcCtD
Lamivudine—Infection—Vincristine—colon cancer	0.000189	0.00205	CcSEcCtD
Lamivudine—Convulsion—Fluorouracil—colon cancer	0.000189	0.00205	CcSEcCtD
Lamivudine—ABCB1—renal system—colon cancer	0.000188	0.00252	CbGeAlD
Lamivudine—Confusional state—Irinotecan—colon cancer	0.000187	0.00203	CcSEcCtD
Lamivudine—Nervous system disorder—Vincristine—colon cancer	0.000187	0.00203	CcSEcCtD
Lamivudine—Thrombocytopenia—Vincristine—colon cancer	0.000187	0.00202	CcSEcCtD
Lamivudine—Oedema—Irinotecan—colon cancer	0.000186	0.00201	CcSEcCtD
Lamivudine—Anaphylactic shock—Irinotecan—colon cancer	0.000186	0.00201	CcSEcCtD
Lamivudine—Chest pain—Fluorouracil—colon cancer	0.000185	0.00201	CcSEcCtD
Lamivudine—Myalgia—Fluorouracil—colon cancer	0.000185	0.00201	CcSEcCtD
Lamivudine—Infection—Irinotecan—colon cancer	0.000184	0.002	CcSEcCtD
Lamivudine—Hyperhidrosis—Vincristine—colon cancer	0.000184	0.002	CcSEcCtD
Lamivudine—Hepatobiliary disease—Capecitabine—colon cancer	0.000184	0.002	CcSEcCtD
Lamivudine—Epistaxis—Capecitabine—colon cancer	0.000184	0.00199	CcSEcCtD
Lamivudine—Discomfort—Fluorouracil—colon cancer	0.000183	0.00199	CcSEcCtD
Lamivudine—Shock—Irinotecan—colon cancer	0.000183	0.00198	CcSEcCtD
Lamivudine—Nervous system disorder—Irinotecan—colon cancer	0.000182	0.00197	CcSEcCtD
Lamivudine—Agranulocytosis—Capecitabine—colon cancer	0.000182	0.00197	CcSEcCtD
Lamivudine—Thrombocytopenia—Irinotecan—colon cancer	0.000182	0.00197	CcSEcCtD
Lamivudine—Anorexia—Vincristine—colon cancer	0.000182	0.00197	CcSEcCtD
Lamivudine—Hyperhidrosis—Irinotecan—colon cancer	0.000179	0.00195	CcSEcCtD
Lamivudine—Confusional state—Fluorouracil—colon cancer	0.000179	0.00194	CcSEcCtD
Lamivudine—ABCG2—lymph node—colon cancer	0.000178	0.0024	CbGeAlD
Lamivudine—Mood swings—Methotrexate—colon cancer	0.000178	0.00193	CcSEcCtD
Lamivudine—Hypotension—Vincristine—colon cancer	0.000178	0.00193	CcSEcCtD
Lamivudine—Oedema—Fluorouracil—colon cancer	0.000178	0.00193	CcSEcCtD
Lamivudine—Anaphylactic shock—Fluorouracil—colon cancer	0.000178	0.00193	CcSEcCtD
Lamivudine—Anorexia—Irinotecan—colon cancer	0.000177	0.00192	CcSEcCtD
Lamivudine—Infection—Fluorouracil—colon cancer	0.000177	0.00191	CcSEcCtD
Lamivudine—Rhinitis—Capecitabine—colon cancer	0.000175	0.0019	CcSEcCtD
Lamivudine—Hepatitis—Capecitabine—colon cancer	0.000175	0.0019	CcSEcCtD
Lamivudine—Nervous system disorder—Fluorouracil—colon cancer	0.000174	0.00189	CcSEcCtD
Lamivudine—Thrombocytopenia—Fluorouracil—colon cancer	0.000174	0.00189	CcSEcCtD
Lamivudine—Hypoaesthesia—Capecitabine—colon cancer	0.000174	0.00189	CcSEcCtD
Lamivudine—Liver function test abnormal—Methotrexate—colon cancer	0.000174	0.00188	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000174	0.00188	CcSEcCtD
Lamivudine—Pharyngitis—Capecitabine—colon cancer	0.000174	0.00188	CcSEcCtD
Lamivudine—Hypotension—Irinotecan—colon cancer	0.000173	0.00188	CcSEcCtD
Lamivudine—Insomnia—Vincristine—colon cancer	0.000172	0.00187	CcSEcCtD
Lamivudine—Connective tissue disorder—Capecitabine—colon cancer	0.000172	0.00186	CcSEcCtD
Lamivudine—Paraesthesia—Vincristine—colon cancer	0.000171	0.00186	CcSEcCtD
Lamivudine—Anorexia—Fluorouracil—colon cancer	0.000169	0.00184	CcSEcCtD
Lamivudine—Insomnia—Irinotecan—colon cancer	0.000168	0.00182	CcSEcCtD
Lamivudine—Paraesthesia—Irinotecan—colon cancer	0.000167	0.00181	CcSEcCtD
Lamivudine—Hypotension—Fluorouracil—colon cancer	0.000166	0.0018	CcSEcCtD
Lamivudine—Decreased appetite—Vincristine—colon cancer	0.000166	0.0018	CcSEcCtD
Lamivudine—Dyspnoea—Irinotecan—colon cancer	0.000165	0.00179	CcSEcCtD
Lamivudine—Erythema multiforme—Capecitabine—colon cancer	0.000165	0.00179	CcSEcCtD
Lamivudine—Somnolence—Irinotecan—colon cancer	0.000165	0.00179	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Vincristine—colon cancer	0.000165	0.00178	CcSEcCtD
Lamivudine—Fatigue—Vincristine—colon cancer	0.000164	0.00178	CcSEcCtD
Lamivudine—Dyspepsia—Irinotecan—colon cancer	0.000163	0.00177	CcSEcCtD
Lamivudine—Pain—Vincristine—colon cancer	0.000163	0.00177	CcSEcCtD
Lamivudine—Constipation—Vincristine—colon cancer	0.000163	0.00177	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000162	0.00176	CcSEcCtD
Lamivudine—Decreased appetite—Irinotecan—colon cancer	0.000161	0.00175	CcSEcCtD
Lamivudine—Insomnia—Fluorouracil—colon cancer	0.000161	0.00174	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00016	0.00174	CcSEcCtD
Lamivudine—Fatigue—Irinotecan—colon cancer	0.00016	0.00173	CcSEcCtD
Lamivudine—Paraesthesia—Fluorouracil—colon cancer	0.00016	0.00173	CcSEcCtD
Lamivudine—Pancreatitis—Methotrexate—colon cancer	0.000159	0.00173	CcSEcCtD
Lamivudine—Constipation—Irinotecan—colon cancer	0.000159	0.00172	CcSEcCtD
Lamivudine—Pain—Irinotecan—colon cancer	0.000159	0.00172	CcSEcCtD
Lamivudine—Dyspnoea—Fluorouracil—colon cancer	0.000158	0.00172	CcSEcCtD
Lamivudine—Somnolence—Fluorouracil—colon cancer	0.000158	0.00171	CcSEcCtD
Lamivudine—Immune system disorder—Capecitabine—colon cancer	0.000158	0.00171	CcSEcCtD
Lamivudine—Mediastinal disorder—Capecitabine—colon cancer	0.000158	0.00171	CcSEcCtD
Lamivudine—Chills—Capecitabine—colon cancer	0.000157	0.0017	CcSEcCtD
Lamivudine—Dyspepsia—Fluorouracil—colon cancer	0.000156	0.0017	CcSEcCtD
Lamivudine—Abdominal discomfort—Methotrexate—colon cancer	0.000156	0.00169	CcSEcCtD
Lamivudine—Gastrointestinal pain—Vincristine—colon cancer	0.000156	0.00169	CcSEcCtD
Lamivudine—ABCB1—lymphoid tissue—colon cancer	0.000156	0.00209	CbGeAlD
Lamivudine—Decreased appetite—Fluorouracil—colon cancer	0.000155	0.00168	CcSEcCtD
Lamivudine—Alopecia—Capecitabine—colon cancer	0.000155	0.00168	CcSEcCtD
Lamivudine—Pancytopenia—Methotrexate—colon cancer	0.000154	0.00167	CcSEcCtD
Lamivudine—ABCB1—digestive system—colon cancer	0.000154	0.00207	CbGeAlD
Lamivudine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000153	0.00166	CcSEcCtD
Lamivudine—Feeling abnormal—Irinotecan—colon cancer	0.000153	0.00166	CcSEcCtD
Lamivudine—Erythema—Capecitabine—colon cancer	0.000152	0.00165	CcSEcCtD
Lamivudine—Malnutrition—Capecitabine—colon cancer	0.000152	0.00165	CcSEcCtD
Lamivudine—Dysuria—Methotrexate—colon cancer	0.000152	0.00165	CcSEcCtD
Lamivudine—Neutropenia—Methotrexate—colon cancer	0.000152	0.00165	CcSEcCtD
Lamivudine—Pain—Fluorouracil—colon cancer	0.000152	0.00165	CcSEcCtD
Lamivudine—Gastrointestinal pain—Irinotecan—colon cancer	0.000152	0.00165	CcSEcCtD
Lamivudine—Abdominal pain—Vincristine—colon cancer	0.000151	0.00163	CcSEcCtD
Lamivudine—Body temperature increased—Vincristine—colon cancer	0.000151	0.00163	CcSEcCtD
Lamivudine—Flatulence—Capecitabine—colon cancer	0.00015	0.00163	CcSEcCtD
Lamivudine—Dysgeusia—Capecitabine—colon cancer	0.000149	0.00162	CcSEcCtD
Lamivudine—Back pain—Capecitabine—colon cancer	0.000147	0.0016	CcSEcCtD
Lamivudine—Body temperature increased—Irinotecan—colon cancer	0.000147	0.00159	CcSEcCtD
Lamivudine—Abdominal pain—Irinotecan—colon cancer	0.000147	0.00159	CcSEcCtD
Lamivudine—Feeling abnormal—Fluorouracil—colon cancer	0.000146	0.00159	CcSEcCtD
Lamivudine—Muscle spasms—Capecitabine—colon cancer	0.000146	0.00159	CcSEcCtD
Lamivudine—Depression—Methotrexate—colon cancer	0.000145	0.00157	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000144	0.00156	CcSEcCtD
Lamivudine—Tremor—Capecitabine—colon cancer	0.000143	0.00155	CcSEcCtD
Lamivudine—Renal failure—Methotrexate—colon cancer	0.000143	0.00155	CcSEcCtD
Lamivudine—ABCB1—bone marrow—colon cancer	0.000142	0.00191	CbGeAlD
Lamivudine—Stomatitis—Methotrexate—colon cancer	0.000141	0.00153	CcSEcCtD
Lamivudine—Ill-defined disorder—Capecitabine—colon cancer	0.000141	0.00153	CcSEcCtD
Lamivudine—Urticaria—Fluorouracil—colon cancer	0.000141	0.00153	CcSEcCtD
Lamivudine—Anaemia—Capecitabine—colon cancer	0.000141	0.00153	CcSEcCtD
Lamivudine—Body temperature increased—Fluorouracil—colon cancer	0.000141	0.00152	CcSEcCtD
Lamivudine—Hypersensitivity—Vincristine—colon cancer	0.00014	0.00152	CcSEcCtD
Lamivudine—Sweating—Methotrexate—colon cancer	0.000139	0.00151	CcSEcCtD
Lamivudine—Malaise—Capecitabine—colon cancer	0.000137	0.00149	CcSEcCtD
Lamivudine—Hepatobiliary disease—Methotrexate—colon cancer	0.000137	0.00149	CcSEcCtD
Lamivudine—Epistaxis—Methotrexate—colon cancer	0.000137	0.00148	CcSEcCtD
Lamivudine—Vertigo—Capecitabine—colon cancer	0.000137	0.00148	CcSEcCtD
Lamivudine—Hypersensitivity—Irinotecan—colon cancer	0.000137	0.00148	CcSEcCtD
Lamivudine—Asthenia—Vincristine—colon cancer	0.000137	0.00148	CcSEcCtD
Lamivudine—Syncope—Capecitabine—colon cancer	0.000137	0.00148	CcSEcCtD
Lamivudine—Leukopenia—Capecitabine—colon cancer	0.000136	0.00148	CcSEcCtD
Lamivudine—ABCB1—vagina—colon cancer	0.000136	0.00183	CbGeAlD
Lamivudine—Agranulocytosis—Methotrexate—colon cancer	0.000135	0.00147	CcSEcCtD
Lamivudine—Loss of consciousness—Capecitabine—colon cancer	0.000134	0.00145	CcSEcCtD
Lamivudine—Asthenia—Irinotecan—colon cancer	0.000133	0.00144	CcSEcCtD
Lamivudine—Cough—Capecitabine—colon cancer	0.000133	0.00144	CcSEcCtD
Lamivudine—Hypersensitivity—Fluorouracil—colon cancer	0.000131	0.00142	CcSEcCtD
Lamivudine—Diarrhoea—Vincristine—colon cancer	0.00013	0.00141	CcSEcCtD
Lamivudine—Hepatitis—Methotrexate—colon cancer	0.00013	0.00141	CcSEcCtD
Lamivudine—Chest pain—Capecitabine—colon cancer	0.00013	0.0014	CcSEcCtD
Lamivudine—Myalgia—Capecitabine—colon cancer	0.00013	0.0014	CcSEcCtD
Lamivudine—Arthralgia—Capecitabine—colon cancer	0.00013	0.0014	CcSEcCtD
Lamivudine—Pharyngitis—Methotrexate—colon cancer	0.000129	0.0014	CcSEcCtD
Lamivudine—Anxiety—Capecitabine—colon cancer	0.000129	0.0014	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000129	0.0014	CcSEcCtD
Lamivudine—Discomfort—Capecitabine—colon cancer	0.000128	0.00139	CcSEcCtD
Lamivudine—Diarrhoea—Irinotecan—colon cancer	0.000127	0.00138	CcSEcCtD
Lamivudine—Dry mouth—Capecitabine—colon cancer	0.000127	0.00137	CcSEcCtD
Lamivudine—Dizziness—Vincristine—colon cancer	0.000126	0.00137	CcSEcCtD
Lamivudine—Pruritus—Fluorouracil—colon cancer	0.000126	0.00136	CcSEcCtD
Lamivudine—Confusional state—Capecitabine—colon cancer	0.000125	0.00136	CcSEcCtD
Lamivudine—Oedema—Capecitabine—colon cancer	0.000124	0.00135	CcSEcCtD
Lamivudine—Infection—Capecitabine—colon cancer	0.000123	0.00134	CcSEcCtD
Lamivudine—Erythema multiforme—Methotrexate—colon cancer	0.000123	0.00133	CcSEcCtD
Lamivudine—Dizziness—Irinotecan—colon cancer	0.000123	0.00133	CcSEcCtD
Lamivudine—Shock—Capecitabine—colon cancer	0.000122	0.00132	CcSEcCtD
Lamivudine—Nervous system disorder—Capecitabine—colon cancer	0.000122	0.00132	CcSEcCtD
Lamivudine—Diarrhoea—Fluorouracil—colon cancer	0.000122	0.00132	CcSEcCtD
Lamivudine—Thrombocytopenia—Capecitabine—colon cancer	0.000122	0.00132	CcSEcCtD
Lamivudine—Vomiting—Vincristine—colon cancer	0.000121	0.00131	CcSEcCtD
Lamivudine—Skin disorder—Capecitabine—colon cancer	0.000121	0.00131	CcSEcCtD
Lamivudine—Rash—Vincristine—colon cancer	0.00012	0.0013	CcSEcCtD
Lamivudine—Hyperhidrosis—Capecitabine—colon cancer	0.00012	0.0013	CcSEcCtD
Lamivudine—Dermatitis—Vincristine—colon cancer	0.00012	0.0013	CcSEcCtD
Lamivudine—Headache—Vincristine—colon cancer	0.000119	0.00129	CcSEcCtD
Lamivudine—Anorexia—Capecitabine—colon cancer	0.000118	0.00128	CcSEcCtD
Lamivudine—Vomiting—Irinotecan—colon cancer	0.000118	0.00128	CcSEcCtD
Lamivudine—Immune system disorder—Methotrexate—colon cancer	0.000118	0.00127	CcSEcCtD
Lamivudine—Dizziness—Fluorouracil—colon cancer	0.000118	0.00127	CcSEcCtD
Lamivudine—Mediastinal disorder—Methotrexate—colon cancer	0.000117	0.00127	CcSEcCtD
Lamivudine—Rash—Irinotecan—colon cancer	0.000117	0.00127	CcSEcCtD
Lamivudine—Dermatitis—Irinotecan—colon cancer	0.000117	0.00127	CcSEcCtD
Lamivudine—Chills—Methotrexate—colon cancer	0.000117	0.00127	CcSEcCtD
Lamivudine—Headache—Irinotecan—colon cancer	0.000116	0.00126	CcSEcCtD
Lamivudine—Hypotension—Capecitabine—colon cancer	0.000116	0.00126	CcSEcCtD
Lamivudine—Alopecia—Methotrexate—colon cancer	0.000115	0.00125	CcSEcCtD
Lamivudine—ABCB1—liver—colon cancer	0.000115	0.00154	CbGeAlD
Lamivudine—Malnutrition—Methotrexate—colon cancer	0.000113	0.00123	CcSEcCtD
Lamivudine—Erythema—Methotrexate—colon cancer	0.000113	0.00123	CcSEcCtD
Lamivudine—Nausea—Vincristine—colon cancer	0.000113	0.00123	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000113	0.00123	CcSEcCtD
Lamivudine—Vomiting—Fluorouracil—colon cancer	0.000113	0.00123	CcSEcCtD
Lamivudine—Insomnia—Capecitabine—colon cancer	0.000112	0.00122	CcSEcCtD
Lamivudine—Rash—Fluorouracil—colon cancer	0.000112	0.00122	CcSEcCtD
Lamivudine—Dermatitis—Fluorouracil—colon cancer	0.000112	0.00121	CcSEcCtD
Lamivudine—Paraesthesia—Capecitabine—colon cancer	0.000112	0.00121	CcSEcCtD
Lamivudine—Headache—Fluorouracil—colon cancer	0.000111	0.00121	CcSEcCtD
Lamivudine—Dysgeusia—Methotrexate—colon cancer	0.000111	0.0012	CcSEcCtD
Lamivudine—Dyspnoea—Capecitabine—colon cancer	0.000111	0.0012	CcSEcCtD
Lamivudine—Nausea—Irinotecan—colon cancer	0.00011	0.0012	CcSEcCtD
Lamivudine—Back pain—Methotrexate—colon cancer	0.00011	0.00119	CcSEcCtD
Lamivudine—Dyspepsia—Capecitabine—colon cancer	0.000109	0.00119	CcSEcCtD
Lamivudine—Decreased appetite—Capecitabine—colon cancer	0.000108	0.00117	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000107	0.00116	CcSEcCtD
Lamivudine—Fatigue—Capecitabine—colon cancer	0.000107	0.00116	CcSEcCtD
Lamivudine—Constipation—Capecitabine—colon cancer	0.000106	0.00115	CcSEcCtD
Lamivudine—Pain—Capecitabine—colon cancer	0.000106	0.00115	CcSEcCtD
Lamivudine—Nausea—Fluorouracil—colon cancer	0.000106	0.00114	CcSEcCtD
Lamivudine—Ill-defined disorder—Methotrexate—colon cancer	0.000105	0.00114	CcSEcCtD
Lamivudine—Anaemia—Methotrexate—colon cancer	0.000105	0.00114	CcSEcCtD
Lamivudine—Feeling abnormal—Capecitabine—colon cancer	0.000102	0.00111	CcSEcCtD
Lamivudine—Malaise—Methotrexate—colon cancer	0.000102	0.00111	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—colon cancer	0.000102	0.0011	CcSEcCtD
Lamivudine—Gastrointestinal pain—Capecitabine—colon cancer	0.000102	0.0011	CcSEcCtD
Lamivudine—Leukopenia—Methotrexate—colon cancer	0.000101	0.0011	CcSEcCtD
Lamivudine—Cough—Methotrexate—colon cancer	9.89e-05	0.00107	CcSEcCtD
Lamivudine—Urticaria—Capecitabine—colon cancer	9.87e-05	0.00107	CcSEcCtD
Lamivudine—Abdominal pain—Capecitabine—colon cancer	9.82e-05	0.00106	CcSEcCtD
Lamivudine—Body temperature increased—Capecitabine—colon cancer	9.82e-05	0.00106	CcSEcCtD
Lamivudine—Convulsion—Methotrexate—colon cancer	9.82e-05	0.00106	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—colon cancer	9.65e-05	0.00105	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—colon cancer	9.65e-05	0.00105	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—colon cancer	9.65e-05	0.00105	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.58e-05	0.00104	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—colon cancer	9.53e-05	0.00103	CcSEcCtD
Lamivudine—Confusional state—Methotrexate—colon cancer	9.32e-05	0.00101	CcSEcCtD
Lamivudine—Anaphylactic shock—Methotrexate—colon cancer	9.25e-05	0.001	CcSEcCtD
Lamivudine—Infection—Methotrexate—colon cancer	9.19e-05	0.000996	CcSEcCtD
Lamivudine—Hypersensitivity—Capecitabine—colon cancer	9.15e-05	0.000992	CcSEcCtD
Lamivudine—Nervous system disorder—Methotrexate—colon cancer	9.07e-05	0.000983	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—colon cancer	9.05e-05	0.000982	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—colon cancer	8.98e-05	0.000974	CcSEcCtD
Lamivudine—Hyperhidrosis—Methotrexate—colon cancer	8.94e-05	0.000969	CcSEcCtD
Lamivudine—Asthenia—Capecitabine—colon cancer	8.91e-05	0.000966	CcSEcCtD
Lamivudine—Anorexia—Methotrexate—colon cancer	8.82e-05	0.000956	CcSEcCtD
Lamivudine—ABCB1—lymph node—colon cancer	8.79e-05	0.00118	CbGeAlD
Lamivudine—Pruritus—Capecitabine—colon cancer	8.79e-05	0.000953	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	8.73e-05	0.00131	CbGpPWpGaD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	8.68e-05	0.0013	CbGpPWpGaD
Lamivudine—Hypotension—Methotrexate—colon cancer	8.64e-05	0.000937	CcSEcCtD
Lamivudine—ABCC1—Metabolism—CA7—colon cancer	8.64e-05	0.00129	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.62e-05	0.00129	CbGpPWpGaD
Lamivudine—Diarrhoea—Capecitabine—colon cancer	8.5e-05	0.000921	CcSEcCtD
Lamivudine—PCYT2—Metabolism—ABCB1—colon cancer	8.44e-05	0.00127	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ABCB1—colon cancer	8.44e-05	0.00127	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ABCB1—colon cancer	8.44e-05	0.00127	CbGpPWpGaD
Lamivudine—Musculoskeletal discomfort—Methotrexate—colon cancer	8.43e-05	0.000913	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—colon cancer	8.36e-05	0.000907	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—colon cancer	8.3e-05	0.0009	CcSEcCtD
Lamivudine—PCYT2—Metabolism—TYMS—colon cancer	8.29e-05	0.00124	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—TYMS—colon cancer	8.29e-05	0.00124	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—TYMS—colon cancer	8.29e-05	0.00124	CbGpPWpGaD
Lamivudine—Dyspnoea—Methotrexate—colon cancer	8.24e-05	0.000894	CcSEcCtD
Lamivudine—Somnolence—Methotrexate—colon cancer	8.22e-05	0.000891	CcSEcCtD
Lamivudine—Dizziness—Capecitabine—colon cancer	8.22e-05	0.000891	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—colon cancer	8.14e-05	0.000883	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—colon cancer	8.04e-05	0.000872	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	8.03e-05	0.0012	CbGpPWpGaD
Lamivudine—Gastrointestinal disorder—Methotrexate—colon cancer	7.98e-05	0.000866	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—colon cancer	7.97e-05	0.000864	CcSEcCtD
Lamivudine—Pain—Methotrexate—colon cancer	7.91e-05	0.000857	CcSEcCtD
Lamivudine—Vomiting—Capecitabine—colon cancer	7.9e-05	0.000856	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.86e-05	0.00118	CbGpPWpGaD
Lamivudine—Rash—Capecitabine—colon cancer	7.83e-05	0.000849	CcSEcCtD
Lamivudine—Dermatitis—Capecitabine—colon cancer	7.83e-05	0.000848	CcSEcCtD
Lamivudine—Headache—Capecitabine—colon cancer	7.78e-05	0.000844	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	7.76e-05	0.00116	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—VEGFA—colon cancer	7.72e-05	0.00116	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	7.71e-05	0.00116	CbGpPWpGaD
Lamivudine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	7.63e-05	0.00114	CbGpPWpGaD
Lamivudine—Feeling abnormal—Methotrexate—colon cancer	7.62e-05	0.000826	CcSEcCtD
Lamivudine—ABCG2—Metabolism—CA7—colon cancer	7.6e-05	0.00114	CbGpPWpGaD
Lamivudine—Gastrointestinal pain—Methotrexate—colon cancer	7.56e-05	0.00082	CcSEcCtD
Lamivudine—SLC22A2—Metabolism—CA7—colon cancer	7.52e-05	0.00113	CbGpPWpGaD
Lamivudine—Nausea—Capecitabine—colon cancer	7.38e-05	0.0008	CcSEcCtD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	7.35e-05	0.0011	CbGpPWpGaD
Lamivudine—Urticaria—Methotrexate—colon cancer	7.35e-05	0.000796	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—colon cancer	7.31e-05	0.000793	CcSEcCtD
Lamivudine—Abdominal pain—Methotrexate—colon cancer	7.31e-05	0.000793	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—CHST5—colon cancer	7.26e-05	0.00109	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ODC1—colon cancer	7.26e-05	0.00109	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—TGFB1—colon cancer	7.08e-05	0.00106	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CA7—colon cancer	7.01e-05	0.00105	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	6.97e-05	0.00104	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ABCB1—colon cancer	6.88e-05	0.00103	CbGpPWpGaD
Lamivudine—Hypersensitivity—Methotrexate—colon cancer	6.81e-05	0.000739	CcSEcCtD
Lamivudine—PGK1—Metabolism—TYMS—colon cancer	6.76e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	6.75e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	6.73e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CHST5—colon cancer	6.68e-05	0.001	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ODC1—colon cancer	6.68e-05	0.001	CbGpPWpGaD
Lamivudine—Asthenia—Methotrexate—colon cancer	6.64e-05	0.000719	CcSEcCtD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	6.6e-05	0.000989	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.56e-05	0.000983	CbGpPWpGaD
Lamivudine—Pruritus—Methotrexate—colon cancer	6.54e-05	0.000709	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.54e-05	0.00098	CbGpPWpGaD
Lamivudine—PGK1—Disease—FGFR3—colon cancer	6.45e-05	0.000967	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ABCB1—colon cancer	6.39e-05	0.000959	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.38e-05	0.000956	CbGpPWpGaD
Lamivudine—Diarrhoea—Methotrexate—colon cancer	6.33e-05	0.000686	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—TYMS—colon cancer	6.28e-05	0.000942	CbGpPWpGaD
Lamivudine—ABCC1—Disease—LGR5—colon cancer	6.25e-05	0.000937	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CHST5—colon cancer	6.25e-05	0.000937	CbGpPWpGaD
Lamivudine—Dizziness—Methotrexate—colon cancer	6.12e-05	0.000663	CcSEcCtD
Lamivudine—PGK1—Disease—APC—colon cancer	5.92e-05	0.000888	CbGpPWpGaD
Lamivudine—Vomiting—Methotrexate—colon cancer	5.88e-05	0.000637	CcSEcCtD
Lamivudine—PCYT2—Metabolism—PPARG—colon cancer	5.87e-05	0.00088	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PPARG—colon cancer	5.87e-05	0.00088	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PPARG—colon cancer	5.87e-05	0.00088	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ABCB1—colon cancer	5.85e-05	0.000877	CbGpPWpGaD
Lamivudine—Rash—Methotrexate—colon cancer	5.83e-05	0.000632	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—colon cancer	5.83e-05	0.000632	CcSEcCtD
Lamivudine—Headache—Methotrexate—colon cancer	5.79e-05	0.000628	CcSEcCtD
Lamivudine—NME2—Metabolism—TYMS—colon cancer	5.74e-05	0.000861	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	5.67e-05	0.00085	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	5.67e-05	0.000849	CbGpPWpGaD
Lamivudine—PGK1—Disease—BRAF—colon cancer	5.56e-05	0.000834	CbGpPWpGaD
Lamivudine—Nausea—Methotrexate—colon cancer	5.49e-05	0.000596	CcSEcCtD
Lamivudine—ABCC1—Metabolism—CHST5—colon cancer	5.23e-05	0.000784	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ODC1—colon cancer	5.23e-05	0.000784	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.83e-05	0.000725	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PPARG—colon cancer	4.79e-05	0.000717	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—TGFB1—colon cancer	4.65e-05	0.000698	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTGS2—colon cancer	4.62e-05	0.000692	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTGS2—colon cancer	4.62e-05	0.000692	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTGS2—colon cancer	4.62e-05	0.000692	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CHST5—colon cancer	4.6e-05	0.00069	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ODC1—colon cancer	4.6e-05	0.00069	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—MYC—colon cancer	4.59e-05	0.000688	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ODC1—colon cancer	4.56e-05	0.000683	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CHST5—colon cancer	4.56e-05	0.000683	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.53e-05	0.000679	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTGS2—colon cancer	4.49e-05	0.000674	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AXIN2—colon cancer	4.49e-05	0.000673	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PPARG—colon cancer	4.45e-05	0.000667	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ABCB1—colon cancer	4.43e-05	0.000665	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—TGFB1—colon cancer	4.38e-05	0.000656	CbGpPWpGaD
Lamivudine—NME1—Metabolism—TYMS—colon cancer	4.35e-05	0.000653	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CHST5—colon cancer	4.25e-05	0.000637	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ODC1—colon cancer	4.25e-05	0.000637	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	4.23e-05	0.000634	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	4.21e-05	0.000631	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	4.17e-05	0.000625	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA7—colon cancer	4.11e-05	0.000616	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ABCB1—colon cancer	4.1e-05	0.000615	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PPARG—colon cancer	4.07e-05	0.00061	CbGpPWpGaD
Lamivudine—PGK1—Disease—CTNNB1—colon cancer	4.02e-05	0.000603	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—BRAF—colon cancer	3.94e-05	0.000591	CbGpPWpGaD
Lamivudine—PGK1—Disease—CDKN1A—colon cancer	3.93e-05	0.000589	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—EP300—colon cancer	3.84e-05	0.000576	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—EP300—colon cancer	3.84e-05	0.000576	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—EP300—colon cancer	3.84e-05	0.000576	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	3.77e-05	0.000565	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.77e-05	0.000565	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTGS2—colon cancer	3.76e-05	0.000564	CbGpPWpGaD
Lamivudine—PGK1—Disease—EP300—colon cancer	3.74e-05	0.00056	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—TGFB1—colon cancer	3.69e-05	0.000553	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CASP3—colon cancer	3.64e-05	0.000546	CbGpPWpGaD
Lamivudine—PGK1—Disease—SRC—colon cancer	3.64e-05	0.000545	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.57e-05	0.000535	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	3.54e-05	0.000531	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	3.51e-05	0.000527	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTGS2—colon cancer	3.5e-05	0.000525	CbGpPWpGaD
Lamivudine—PGK1—Disease—NRAS—colon cancer	3.5e-05	0.000524	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.47e-05	0.000521	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	3.42e-05	0.000513	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.35e-05	0.000502	CbGpPWpGaD
Lamivudine—PGK1—Disease—MYC—colon cancer	3.26e-05	0.000488	CbGpPWpGaD
Lamivudine—PGK1—Disease—TGFB1—colon cancer	3.25e-05	0.000487	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—BRAF—colon cancer	3.24e-05	0.000486	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTGS2—colon cancer	3.2e-05	0.00048	CbGpPWpGaD
Lamivudine—PGK1—Disease—EGFR—colon cancer	3.19e-05	0.000478	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	3.14e-05	0.000471	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—EP300—colon cancer	3.13e-05	0.000469	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—VEGFA—colon cancer	3.09e-05	0.000463	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PPARG—colon cancer	3.08e-05	0.000462	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	3.08e-05	0.000462	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ABCB1—colon cancer	3.04e-05	0.000456	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—BRAF—colon cancer	3.02e-05	0.000453	CbGpPWpGaD
Lamivudine—PGK1—Disease—KRAS—colon cancer	3.01e-05	0.000451	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.99e-05	0.000448	CbGpPWpGaD
Lamivudine—DCK—Metabolism—TYMS—colon cancer	2.99e-05	0.000448	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	2.95e-05	0.000443	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—EP300—colon cancer	2.91e-05	0.000436	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PIK3CA—colon cancer	2.84e-05	0.000426	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PIK3CA—colon cancer	2.84e-05	0.000426	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PIK3CA—colon cancer	2.84e-05	0.000426	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.84e-05	0.000425	CbGpPWpGaD
Lamivudine—PGK1—Disease—PIK3CA—colon cancer	2.77e-05	0.000415	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.76e-05	0.000413	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	2.67e-05	0.000401	CbGpPWpGaD
Lamivudine—NME2—Metabolism—EP300—colon cancer	2.66e-05	0.000399	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.6e-05	0.000389	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.57e-05	0.000385	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—colon cancer	2.56e-05	0.000384	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.55e-05	0.000382	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ODC1—colon cancer	2.49e-05	0.000373	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CHST5—colon cancer	2.49e-05	0.000373	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—colon cancer	2.43e-05	0.000364	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ABCB1—colon cancer	2.4e-05	0.000359	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—colon cancer	2.32e-05	0.000348	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—colon cancer	2.32e-05	0.000348	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—colon cancer	2.32e-05	0.000348	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CA—colon cancer	2.32e-05	0.000347	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.28e-05	0.000341	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—colon cancer	2.26e-05	0.000339	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	2.18e-05	0.000327	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.17e-05	0.000325	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.16e-05	0.000324	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—colon cancer	2.15e-05	0.000323	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—colon cancer	2.12e-05	0.000317	CbGpPWpGaD
Lamivudine—NME1—Metabolism—EP300—colon cancer	2.02e-05	0.000302	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—colon cancer	1.97e-05	0.000295	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	1.94e-05	0.000291	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.94e-05	0.00029	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ABCB1—colon cancer	1.92e-05	0.000288	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—colon cancer	1.89e-05	0.000284	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TYMS—colon cancer	1.89e-05	0.000283	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—EP300—colon cancer	1.86e-05	0.000279	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—colon cancer	1.81e-05	0.000272	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—SRC—colon cancer	1.81e-05	0.000272	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.8e-05	0.00027	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.8e-05	0.000269	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ABCB1—colon cancer	1.76e-05	0.000265	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—colon cancer	1.76e-05	0.000264	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—colon cancer	1.76e-05	0.000264	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.75e-05	0.000262	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NRAS—colon cancer	1.74e-05	0.000261	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TYMS—colon cancer	1.73e-05	0.00026	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.73e-05	0.00026	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.7e-05	0.000255	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.69e-05	0.000254	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—colon cancer	1.66e-05	0.000249	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—colon cancer	1.62e-05	0.000243	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.61e-05	0.000241	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—colon cancer	1.61e-05	0.000241	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.57e-05	0.000235	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.52e-05	0.000229	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—colon cancer	1.5e-05	0.000225	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—colon cancer	1.49e-05	0.000224	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—colon cancer	1.49e-05	0.000223	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.41e-05	0.000212	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.4e-05	0.00021	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.4e-05	0.00021	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—colon cancer	1.39e-05	0.000208	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—colon cancer	1.38e-05	0.000207	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—colon cancer	1.38e-05	0.000207	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—colon cancer	1.38e-05	0.000207	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.37e-05	0.000206	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TYMS—colon cancer	1.36e-05	0.000204	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—colon cancer	1.34e-05	0.0002	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.33e-05	0.0002	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—colon cancer	1.33e-05	0.0002	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.3e-05	0.000194	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR3—colon cancer	1.3e-05	0.000194	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—colon cancer	1.27e-05	0.000191	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—colon cancer	1.23e-05	0.000184	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—colon cancer	1.22e-05	0.000183	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—colon cancer	1.22e-05	0.000182	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—colon cancer	1.2e-05	0.000181	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMS—colon cancer	1.19e-05	0.000179	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.19e-05	0.000179	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—colon cancer	1.19e-05	0.000178	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMS—colon cancer	1.18e-05	0.000177	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.15e-05	0.000173	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—colon cancer	1.13e-05	0.000169	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—colon cancer	1.12e-05	0.000168	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—colon cancer	1.12e-05	0.000168	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMS—colon cancer	1.1e-05	0.000165	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—colon cancer	1.05e-05	0.000158	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.05e-05	0.000157	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—colon cancer	1.02e-05	0.000153	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	9.73e-06	0.000146	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—colon cancer	9.66e-06	0.000145	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—colon cancer	9.62e-06	0.000144	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—colon cancer	9.04e-06	0.000135	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—colon cancer	8.74e-06	0.000131	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—colon cancer	8.46e-06	0.000127	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—colon cancer	8.38e-06	0.000126	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—colon cancer	8.36e-06	0.000125	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—colon cancer	8.08e-06	0.000121	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—colon cancer	8.03e-06	0.00012	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—colon cancer	7.9e-06	0.000118	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—colon cancer	7.81e-06	0.000117	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—colon cancer	7.57e-06	0.000113	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—colon cancer	7.51e-06	0.000113	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SRC—colon cancer	7.31e-06	0.00011	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—colon cancer	7.03e-06	0.000105	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—colon cancer	6.66e-06	9.98e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—colon cancer	6.59e-06	9.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—colon cancer	6.55e-06	9.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—colon cancer	6.53e-06	9.79e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—colon cancer	6.46e-06	9.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMS—colon cancer	6.46e-06	9.69e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—colon cancer	6.4e-06	9.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—colon cancer	6.29e-06	9.44e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—colon cancer	6.14e-06	9.21e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—colon cancer	6.05e-06	9.07e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—colon cancer	5.94e-06	8.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—colon cancer	5.56e-06	8.33e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—colon cancer	5.54e-06	8.3e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—colon cancer	5.48e-06	8.22e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—colon cancer	5.28e-06	7.92e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—colon cancer	5.14e-06	7.71e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—colon cancer	5.11e-06	7.66e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—colon cancer	4.85e-06	7.28e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—colon cancer	4.66e-06	6.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—colon cancer	4.58e-06	6.86e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—colon cancer	4.54e-06	6.81e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—colon cancer	4.1e-06	6.14e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—colon cancer	4.05e-06	6.08e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—colon cancer	3.8e-06	5.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—colon cancer	3.78e-06	5.67e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—colon cancer	3.6e-06	5.4e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—colon cancer	3.35e-06	5.02e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—colon cancer	3.31e-06	4.97e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—colon cancer	3.09e-06	4.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—colon cancer	2.99e-06	4.49e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—colon cancer	2.21e-06	3.32e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—colon cancer	1.81e-06	2.71e-05	CbGpPWpGaD
